Eric Topol on the Creative Destruction of Medicine
2013-04-01 · 64 min · episode 361 · 18 entities
Asserted relationships
-
0.63
evidence rules-v4
Eric Topol on the Creative Destruction of Medicine
-
0.55
evidence rules-v4
Feed author/publisher: Russ Roberts
-
0.55
evidence rules-v4
Feed author/publisher: Library of Economics and Liberty
-
0.40
evidence rules-v4
Feed category: Society & Culture
-
0.40
evidence rules-v4
Feed category: Science
-
0.40
evidence rules-v4
Feed category: Philosophy
-
0.40
evidence rules-v4
Feed category: Education
-
0.40
evidence rules-v4
Feed category: Courses
-
0.40
evidence rules-v4
Feed category: Social Sciences
Entities found in this episode
concepts 12
-
0.50
evidence rules-v4
Feed category: Society & Culture
-
0.50
evidence rules-v4
Feed category: Science
-
0.50
evidence rules-v4
Feed category: Philosophy
-
0.50
evidence rules-v4
Feed category: Education
-
0.50
evidence rules-v4
Feed category: Courses
-
0.50
evidence rules-v4
Feed category: Social Sciences
-
0.40
evidence rules-v4
Feed category: Society & Culture
-
0.40
evidence rules-v4
Feed category: Science
-
0.40
evidence rules-v4
Feed category: Philosophy
-
0.40
evidence rules-v4
Feed category: Education
-
0.40
evidence rules-v4
Feed category: Courses
-
0.40
evidence rules-v4
Feed category: Social Sciences
persons 5
-
0.70
evidence rules-v4
Feed author/publisher: Russ Roberts
-
0.70
evidence rules-v4
Feed author/publisher: Library of Economics and Liberty
-
0.66
evidence rules-v4
Eric Topol on the Creative Destruction of Medicine
-
0.55
evidence rules-v4
Feed author/publisher: Russ Roberts
-
0.55
evidence rules-v4
Feed author/publisher: Library of Economics and Liberty
podcasts 1
-
0.63
evidence rules-v4
Eric Topol on the Creative Destruction of Medicine
Episode description as stored
Eric Topol of the Scripps Research Institute and the author of The Creative Destruction of Medicine talks with EconTalk host Russ Roberts about the ideas in his book. Topics discussed include "evidence-based" medicine, the influence of the pharmaceutical industry, how medicine is currently conducted for the "average" patient, the potential of genomics to improve health care and the power of technology, generally, to transform medicine.